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1112-143 Chronic Effect of Cardiac Resynchronization Therapy 
on Functional Mitral Regurgitation in the Advanced 
Systolic Heart Failure
Kazuya Murata, Rikimaru Oyama, Nobuaki Tanaka, Yasuyuki Hatano, Eizo Akagawa, 
Akihiko Shimizu, Masunori Matsuzaki, Yamaguchi University, Ube, Japan
Acute and chronic effects of cardiac resynchronization therapy (CRT) on functional mitral
regurgitation (FMR) in severe systolic heart failure and thier mechanisms were not still
elucidated. Nine severe heart failure patients with wide QRS complex duration
(>140msec) and FMR received CRT were studied. pical 4- and 2-chamber views were
obtained by tissue Doppler imaging before and one week and 6 months after CRT. Total
Eight regions of interest were placed on mid and base of IVS, posterior, anterolateral and
inferior wall. Time interval from end-diastole to the timing of peak systolic velocity (T-Sm)
in each ROI was obtained and coefficient of variation (CV=standard deviation/mean) of T-
Sm was calculated as an index of LV asynchrony. Mitral valve area (MVA:cm2) and mitral
leaflet tethering lengths defined as the distance between the papillary muscle tips and
the contralateral anterior mitral annulus were measured in the apical 4- and 2-chamber
views and sum of tethering lengths (TLs) was obtained. LV sphericity index (SI: ratio of
LV short- to long-axis dimension in apical four chamber view) was estimated. MR regur-
gitant fraction (MRF:%) was calculated by pulsed Doppler method. Results: CV and
MRF tended to improve one week after CRT (from 0.33 to 0.16, from 64 to 61%, respec-
tively), although LV dimension and MVA unchanged. Six months after CRT, CV and SI
improved (from 0.33 to 0.14 %, from 0.74 to 0.71, P<0.05, respectively) and TLs short-
ened (from 87 to 76mm, P<0.01). MVA and MRF also improved 6 months after CRT(from
9.5 to 8.1cm2, from 64 to 57%, P<0.05, respectively) .Conclusion: In addition to the
improvement of LV synchronicity, the improvement of LV sphericity and tethering effect
caused by reverse remodeling of dilated LV played an important role for reduction of FMR
in chronic phase after CRT.
1112-144 Evaluation of Left Ventricular Function in Pediatric 
Sickle Cell Anemia Patients Using the End Systolic Wall 
Stress-VCFc Relationship
Luke Lamers, Greg Ensing, Caren Goldberg, Robert Gajarski, University of Michigan 
Congenital Heart Center, Ann Arbor, MI
INTRODUCTION: Abnormalities in myocardial function have been documented in sickle
cell anemia (SCA) patients (pts.) using load-dependent indices. Whether the systolic dys-
function results from impaired myocardial contractility or altered loading conditions is
unknown since studies using a load-independent measure of contractility have not been
performed.
PURPOSE: To identify differences in myocardial contractility using the load-independent
end-systolic wall stress (ESSm)-VCFc relationship in SCA pts. compared with age-
matched African American (AA) controls. 
METHODS: 50 healthy AA and 57 SCA pts. 3 mo to 17 yrs were studied. Simultaneous
indirect carotid or brachial pulse tracing, phonocardiogram, ECG, and M-mode tracing of
the LV short-axis were recorded. LV dimensions, ETc, % FS, VCFc, and ESSm were
determined. Using linear regression, the ESSm-VCFc relationship was calculated and
compared between groups.
RESULTS: Age, BSA, and BP were similar between groups. SCA pts. had increased LV
dimensions in systole and diastole, and increased LV mass (p<0.01).
CONCLUSION: SCA pts. have significant LV dilatation consistent with increased preload
and elevated afterload which may contribute to increased ETc and lower FS. Load-inde-
pendent assessment of myocardial function suggests that SCA pts. have reduced con-
tractility compared to controls. These findings may be due to long-standing volume
overload associated with chronic anemia or an effect of microvascular coronary changes
secondary to SCA.
1112-145 Determinants of Severe Pulmonary Hypertension in 
Patients With Severe Aortic Stenosis
Nikhil Kapoor, Padmini Varadarajan, Ramdas G. Pai, Loma Linda University Medical 
Center, Loma Linda, CA
Background: Aortic stenosis (AS) is an increasing problem with the aging population.
Presence of significant pulmonary hypertension in these patients increases the operative
morbidity and mortality. We explored the determinants of severe pulmonary hypertension
in patients with severe AS.
Methods: Our echocardiographic database between 1993 and 2003 was searched for
patients with severe AS defined as a Doppler estimated aortic valve area (AVA) of <0.8
cm2. 949 patients were identified. 626 patients had measurable tricuspid regurgitation
velocity signals forming the study cohort. Doppler estimated pulmonary artery systolic
pressure of >60 mmHg was considered as severe pulmonary hypertension (PHT).
Results: Patient characteristics: age 74+13 years, 50% women, EF 54+20%, AVA
0.74+0.4 cm2. Of the 626 patients, 146 (23%) had severe PHT. Patients with severe PHT
had a smaller AVA (0.65+0.18 vs 0.72+0.19 cm2, p<0.0001) and AVA index (0.37+0.10
vs 0.41+0.11 cm2/m2, p=0.02), lower EF (42+21 vs 56+20%, p<0.0001), larger LV end-
systolic (52+9 vs 49+ 8 mm, p<0.0001) and end-diastolic dimensions (38+10 vs 33+10,
p<0.0001) and a lower relative wall thickness (0.51+0.13 vs 0.56+0.15, p=0.0002). They
also had a greater preponderance of 3 or 4+ mitral regurgitation on a 0-4 scale (55 vs
23%, p<0.001) and a trend towards female preponderance (62 vs 53%, p=0.07). Age, LV
wall thickness and transaortic gradient were not predictive. The independent predictors of
severe PHT were lower EF (p=0.001), greater degree of mitral regurgitation (p=0.0003)
and smaller aortic valve area (p=0.04). In those with EF<40%, the prevalence of severe
PHT was 38% increasing to 52% when AVA was <0.5 cm2.
Conclusions: 1) Severe pulmonary hypetension occurs in about a quarter of patients
with severe AS. 2) It is associated with a smaller AVA, low EF and greater degree of
mitral regurgitation. 3) These findings have implications in the timing of aortic valve
replacement in severe AS.
1112-146 Clinical Predictors and Characteristics of Patients With 
Intra-pulmonary Shunts
Richard A. Santa-Cruz, Matthew D. Pearson, Mauricio G. Cohen, Roshan Shrestha, Park 
W. Willis, IV, Alan Hinderliter, Venu Menon, University of North Carolina, Chapel Hill, NC
Background: Acquired pulmonary arteriovenous shunts are a known complication of
chronic liver disease. A systematic evaluation of the incidence and predictors of intra-pul-
monary shunting (IPS) in patients with liver disease being evaluated for transplantation
has not been previously performed. Methods: We prospectively evaluated for the pres-
ence of IPS in 204 consecutive patients who underwent an echocardiogram with an agi-
tated venous saline contrast bubble study as part of their pre-transplant evaluation. IPS
was diagnosed by the appearance of saline bubbles in the LA after > 3 ventricular beats
post initial appearance in the RA. The shunt size was measured utilizing still frame
images in the apical four chamber view. The bubble count was taken at the heaviest con-
centration still frame and scored using a quantitative scale by two independent observ-
ers. Discordant results were adjudicated by consensus. Results: IPS was documented in
115 out of 204 patients (56.4%). Patients with IPS were more likely to have a history of
alcohol abuse (64.8% vs. 46.9%, p=0.01) and more severe liver disease (Child-Pugh
Class C 72% vs. Class B 54% vs. Class A 44%, p<0.05). No difference was found in alti-
tude of residence for patients with and without IPS (781 vs. 625 feet above sea level
respectively, p=0.11). No differences were also seen in age, sex, body mass index,
smoking, pulmonary function tests, room air PaO2, estimated pulmonary artery pressure,
liver function tests or underlying etiology of liver disease in patients with and without IPS
(all p=NS). Room air PaO2 was significantly higher in patients with Grade 1-2 vs. Grade
3-4 IPS (88mmHg vs. 82mmHg, p<0.04). Two out of 110 (1.8%) patients with evidence of
IPS fulfilled criteria for the Hepatopulomary Syndrome (IPS with liver disease and a PaO2
of less then 60mmHg). Conclusions: The prevalence of IPS in patients with liver dis-
ease was 56.4%. IPS was associated with a history of alcohol abuse and worse class of
liver disease. Increasing IPS grade correlated with worsening room air PaO2. The impact
of IPS positivity and grade on transplant listing and outcomes needs to be determined.
We recommend a saline contrast study should be performed on all patients with liver dis-
ease.
1112-147 Echocardiographic Manifestations of Obstructive Sleep 
Apnea Syndrome at Rest and With Dobutamine: A 
Guide to Effective Medical Management
Antonio Q. Chan, Marietta Abalos Galito, Estrellita Recaro Lua, Noel Antonio, Michael 
Philip Chan, Rosalinda Yutangco Mandreza, Peter Oliver Chan, Zhuo Wen Chen, 
Stanford University Medical Center, Stanford, CA, Chanwell Clinic, Cupertino, CA
Background: Obstructive sleep apnea syndrome (OSA) causes profound disturbance
on cardiovascular physiology. Untreated OSA leads to hypertension that in turn increases
the risks for coronary heart disease, pulmonary hypertension, heart failure and arrhyth-
mias later on in life. We examined the various echocardiographic features on OSA
patients and use these findings to triage patients for aggressive medical management.
Methods: All patients with documented OSA underwent resting echocardiogram (Recho)
and Dobutamine echocardiogram (Decho).265 patients (Male: Female 1.1:1 ages range
32-88) with OSA were entered in the study. Results: Recho: 252 (95%) have diastolic
dysfunction (DDF), 217 (82%) have concentric left ventricular hypertrophy (cLVH), 119
(45%) have pulmonary hypertension (pHPN), 90 (34%) exhibited left ventricular dysfunc-
tion. Decho: 140 (53%) have segmental wall motion abnormality (SWMA), 225 (85%)
have dobutamine-induced left ventricular end-systolic intra-cavitary gradient (LVESG),
maximum gradient range 22-220 mmHg, mean 10-62 mmHg, 69 (26%) have combined
SWMA, and LVESG, 156 (59%) have LVESG but no SWMA. 109 (41%) were shown to
have coronary artery disease by coronary angiogram. DDF and cLVH were present in the
Healthy AA Sickle Cell Anemia p-value
Fractional 
Shortening %
41 +/-4.3 38  +/-5.8 <.01
ETc (msec) 334  +/- 23.7 350  +/- 27.9 <.01
VCFc (circ/s) 1.23 +/- .14 1.09 +/- .19 <.01
ESSm (g/m2) 32.8 +/- 13.5 41.0 +/- 15.3 <.01
ESSm-VCFc 
relationship
VCFc=1.48-
.077(ESSm)R=0.7
VCFc=1.40-
.08(ESSm)R=0.7
<.01
